Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-25

Clinical Trial Update: Cancer Loyalty Card Study 2 (CLOCS-2)

View source ↗

Summary

Clinical Trial Update: Cancer Loyalty Card Study 2 (CLOCS-2) from Imperial College London indicates the study is currently recruiting for multiple cancer indica…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Imperial College London | Conditions: Pancreatic Cancer, Colon Cancer | Status: RECRUITING